Boston Scientific Corporation (BSX)
NYSE: BSX · Real-Time Price · USD
73.85
-2.37 (-3.11%)
At close: Mar 3, 2026, 4:00 PM EST
73.97
+0.12 (0.16%)
After-hours: Mar 3, 2026, 7:59 PM EST
Boston Scientific Stock Forecast
Stock Price Forecast
The 20 analysts with 12-month price forecasts for Boston Scientific stock have an average target of 109.15, with a low estimate of 94 and a high estimate of 128. The average target predicts an increase of 47.80% from the current stock price of 73.85.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Boston Scientific stock from 20 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 10 | 9 | 9 | 8 | 8 | 9 |
| Buy | 12 | 12 | 10 | 9 | 10 | 11 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 22 | 21 | 19 | 17 | 18 | 20 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $112 → $109 | Strong Buy | Maintains | $112 → $109 | +47.60% | Feb 17, 2026 |
| BTIG | BTIG | Strong Buy Reiterates $110 | Strong Buy | Reiterates | $110 | +48.95% | Feb 9, 2026 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $131 → $112 | Strong Buy | Maintains | $131 → $112 | +51.66% | Feb 5, 2026 |
| Citigroup | Citigroup | Strong Buy Maintains $130 → $102 | Strong Buy | Maintains | $130 → $102 | +38.12% | Feb 5, 2026 |
| JP Morgan | JP Morgan | Buy Maintains $135 → $100 | Buy | Maintains | $135 → $100 | +35.41% | Feb 5, 2026 |
Financial Forecast
Revenue This Year
22.49B
from 20.07B
Increased by 12.05%
Revenue Next Year
24.86B
from 22.49B
Increased by 10.51%
EPS This Year
3.50
from 1.94
Increased by 80.54%
EPS Next Year
3.97
from 3.50
Increased by 13.43%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 23.9B | 26.4B | |||
| Avg | 22.5B | 24.9B | |||
| Low | 21.7B | 23.7B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 18.8% | 17.4% | |||
| Avg | 12.1% | 10.5% | |||
| Low | 8.1% | 5.5% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 3.80 | 4.31 | |||
| Avg | 3.50 | 3.97 | |||
| Low | 3.28 | 3.63 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 95.9% | 22.9% | |||
| Avg | 80.5% | 13.4% | |||
| Low | 69.2% | 3.5% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.